Related Experiment Video
Updated: Aug 4, 2026
14:57
Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
Published on: March 23, 2011
Acetylcholine, aging and anatomy: differential effects in the hippocampus
Brain Research
|January 1, 1986
Summary
Aging impairs the hippocampus's response to acetylcholine (ACh). Young rats showed a significantly greater response to ACh in hippocampal CA1 and CA3-4 areas compared to old rats.
Area of Science:
- Neuroscience
- Aging Research
- Acetylcholine Signaling
Background:
- Acetylcholine (ACh) is a neurotransmitter crucial for cognitive functions.
- Hippocampal function, particularly memory, is known to decline with age.
- Age-related changes in neurotransmitter systems, including ACh, may underlie cognitive deficits.
Purpose of the Study:
- To investigate the age-dependent effects of acetylcholine on neuronal activity in specific hippocampal subfields.
- To compare the response to ACh in the CA1 and CA3-4 regions of young and aged rats.
Main Methods:
- Microiontophoretic administration of acetylcholine (ACh) to single neuronal units.
- Electrophysiological recording in the CA1 and CA3-4 areas of the hippocampus.
- Comparison of neuronal responses between young (3-5 months) and old (24-26 months) Fisher 344 rats.
Main Results:
- Single units in the CA1 hippocampal area exhibited a greater response to ACh compared to units in the CA3-4 area in both young and old rats.
- Neuronal responses to ACh were significantly diminished in old rats relative to young rats.
- Baseline firing rates were lower in old rats but did not differ between hippocampal areas, ruling out baseline activity as the cause of differential ACh response.
Conclusions:
- Neuronal responsiveness to acetylcholine in the hippocampus decreases with age.
- The CA1 region shows a more pronounced response to ACh than the CA3-4 region, irrespective of age.
- Age-related decline in hippocampal ACh signaling may contribute to cognitive impairments observed in aging.
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:23Role of Neurotransmitters in Memory
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...